Offer - Urjas Oil for just ₹ 1 X
Mabtas N 500 Injection is a prescription medicine that is available as a Injection. Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia are some of its major therapeutic uses. Other than this, Mabtas N 500 Injection has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Mabtas N 500 Injection. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Common side effects of Mabtas N 500 Injection include Weakness. Besides the aforementioned side effects, there are other adverse effects of Mabtas N 500 Injection as well, which are listed below. Such side effects of Mabtas N 500 Injection normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Mabtas N 500 Injection is Moderate for pregnant women and Severe for women who are breastfeeding. Warnings related to Mabtas N 500 Injection's effects on the liver, heart and kidney, if any, have been listed below.
Mabtas N 500 Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Mabtas N 500 Injection in conditions like Hyperkalemia. Some other conditions that can be affected by Mabtas N 500 Injection are listed in the contraindications section below.
Additionally, Mabtas N 500 Injection may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Mabtas N 500 Injection is not safe while driving, and is is not addictive in nature.
Mabtas N 500 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Mabtas N 500 Injection safe for pregnant women?
Mabtas N may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Mabtas N again without your doctor's advice.
Is the use of Mabtas N 500 Injection safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Mabtas N. It should only be taken after medical advice.
What is the effect of Mabtas N 500 Injection on the Kidneys?
There can be some harmful effects on your kidneys after taking Mabtas N. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Mabtas N 500 Injection on the Liver?
Mabtas N is not harmful for the liver.
What is the effect of Mabtas N 500 Injection on the Heart?
You may experience side effects on your heart after taking Mabtas N. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
If you are suffering from any of the following diseases, you should not take Mabtas N 500 Injection unless your doctor advises you to do so -
Is this Mabtas N 500 Injection habit forming or addictive?
Mabtas N 500 Injection does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Mabtas N 500 Injection as you may feel sleepy.
Is it safe?
Mabtas N 500 Injection is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Mabtas N 500 Injection is unable to treat or cure mental disorders.
Interaction between Food and Mabtas N 500 Injection
You can take Mabtas N 500 Injection with food.
Interaction between Alcohol and Mabtas N 500 Injection
Information about the interaction of Mabtas N 500 Injection and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rituxan (rituximab)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1106-1109
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872